Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Article Life Sciences & Pharma Digital Transformation in the Pharmaceutical Industry September 28, 2023